Masimo Beats Q1 Earnings and Revenue Estimates

VRAYDelisted Stock  USD 0.04  0  5.67%   
Slightly above 62% of ViewRay's investor base is looking to short. The analysis of current outlook of investing in ViewRay suggests that many traders are alarmed regarding ViewRay's prospects. ViewRay's investing sentiment can be driven by a variety of factors including economic data, ViewRay's earnings reports, geopolitical events, and overall market trends.
  
Masimo delivered earnings and revenue surprises of 4.82 percent and 1.38, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock

Read at zacks.com
zacks News
  

ViewRay Fundamental Analysis

We analyze ViewRay's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViewRay using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViewRay based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

ViewRay is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

ViewRay Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ViewRay stock to make a market-neutral strategy. Peer analysis of ViewRay could also be used in its relative valuation, which is a method of valuing ViewRay by comparing valuation metrics with similar companies.

Peers

ViewRay Related Equities

BBLGBone Biologics   5.56   
0%
73.0%
HSCSHeart Test   2.17   
0%
28.0%
ATECAlphatec Holdings   0.11   
0%
1.0%
AVNSAvanos Medical   0.62   
8.0%
0%
DCTHDelcath Systems   0.84   
11.0%
0%
AXGNAxogen   1.49   
19.0%
0%
INGNInogen   1.63   
21.0%
0%
AORTArtivion   1.74   
22.0%
0%
SGHTSight Sciences   2.49   
32.0%
0%
OFIXOrthofix Medical   2.69   
35.0%
0%
ESTAEstablishment Labs   2.81   
36.0%
0%
ANIKAnika Therapeutics   3.30   
43.0%
0%
CVRXCVRx   4.77   
62.0%
0%
VVOSVivos Therapeutics   6.24   
82.0%
0%
NPCENeuropace   6.26   
82.0%
0%
TIVCTivic Health   7.60   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in ViewRay Stock

If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules